FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us

Resources

  • Videos
  • Research Reports
  • FAQ

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Kalaris Therapeutics Inc Stock AnalysisComprehensive stock analysis for Kalaris Therapeutics Inc (KLRS) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisKLRS
KLRS
Kalaris Therapeutics Inc
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
KLRS
Home🔹Stocks🔹Kalaris Therapeutics Inc

Kalaris Therapeutics Inc

KLRS•NASDAQ

Kalaris Therapeutics Inc

KLRS•NASDAQ
Market cap
$62.47M
Sentiment

Your view on KLRS

Mkt Cap
$62.47M
Sentiment
Your view
KLRS
Kalaris Therapeutics Inc
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
KLRS
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Kalaris Therapeutics Inc

Industry
Biotechnology
Sector
Healthcare
CEO
Andrew Oxtoby
Headquarters
US
Industry
Biotechnology
Sector
Healthcare
CEO
Andrew Oxtoby
Headquarters
US
Description

Kalaris Therapeutics Inc operates as a pharmaceutical company. The Company specializes in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.

Infographics

Visual summary of the business at a glance.

FRC Research

Media

Videos and interviews covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks the stock is worth vs. the current price.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Peer Comparison

Comparables

List of peer companies in the same industry.

Ownership & News

Institutional Ownership

Which funds and firms own the stock.

Insider Trading

Recent buying and selling by company executives.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

News

Latest headlines and market coverage.

News

Latest Market News